AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2019
Jun 12, 2019
34491_dirs_2019-06-12_b9d6d89e-54f3-4cb6-8e0b-b5ac9d10774e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-06-10
Reporting Person: ANSARI ABID (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-10 | Common Stock | M | 96618 | $1.20 | Acquired | 96618 | Direct |
| 2019-06-10 | Common Stock | M | 7027 | $1.18 | Acquired | 103645 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-10 | Employee Stock Option (Right to Buy) | $1.20 | M | 96618 | Disposed | 2026-08-10 | Common Stock (96618) | Direct |
| 2019-06-10 | Employee Stock Option (Right to Buy) | $1.18 | M | 7027 | Disposed | 2027-03-23 | Common Stock (7027) | Direct |
Footnotes
F1: The option vests as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three-month period over the following 36 months.
F2: The option vests as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month period over the following 36 months.
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19